nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2E1—Mitoxantrone—lymphatic system cancer	0.027	0.359	CbGbCtD
Sevoflurane—CYP3A4—Cytarabine—lymphatic system cancer	0.0119	0.158	CbGbCtD
Sevoflurane—CYP3A4—Teniposide—lymphatic system cancer	0.0117	0.155	CbGbCtD
Sevoflurane—ALB—Methotrexate—lymphatic system cancer	0.0109	0.145	CbGbCtD
Sevoflurane—CYP3A4—Mitoxantrone—lymphatic system cancer	0.00818	0.109	CbGbCtD
Sevoflurane—Wheezing—Bleomycin—lymphatic system cancer	0.00817	0.00884	CcSEcCtD
Sevoflurane—Bronchospasm—Teniposide—lymphatic system cancer	0.00806	0.00871	CcSEcCtD
Sevoflurane—Leukocytosis—Carmustine—lymphatic system cancer	0.00781	0.00845	CcSEcCtD
Sevoflurane—Liver function test abnormal—Fludarabine—lymphatic system cancer	0.00769	0.00832	CcSEcCtD
Sevoflurane—Respiratory failure—Vincristine—lymphatic system cancer	0.00714	0.00772	CcSEcCtD
Sevoflurane—Dysuria—Fludarabine—lymphatic system cancer	0.00673	0.00728	CcSEcCtD
Sevoflurane—Hyperkalaemia—Mitoxantrone—lymphatic system cancer	0.00671	0.00725	CcSEcCtD
Sevoflurane—Haemoglobin—Teniposide—lymphatic system cancer	0.00659	0.00713	CcSEcCtD
Sevoflurane—Haemorrhage—Teniposide—lymphatic system cancer	0.00656	0.00709	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00655	0.00708	CcSEcCtD
Sevoflurane—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.00649	0.00702	CcSEcCtD
Sevoflurane—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00632	0.00683	CcSEcCtD
Sevoflurane—Renal failure—Fludarabine—lymphatic system cancer	0.00631	0.00682	CcSEcCtD
Sevoflurane—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00619	0.00669	CcSEcCtD
Sevoflurane—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00614	0.00664	CcSEcCtD
Sevoflurane—Chills—Teniposide—lymphatic system cancer	0.00588	0.00636	CcSEcCtD
Sevoflurane—Arrhythmia—Teniposide—lymphatic system cancer	0.00586	0.00633	CcSEcCtD
Sevoflurane—Haemoglobin—Fludarabine—lymphatic system cancer	0.00579	0.00626	CcSEcCtD
Sevoflurane—Haemorrhage—Fludarabine—lymphatic system cancer	0.00576	0.00623	CcSEcCtD
Sevoflurane—Pharyngitis—Fludarabine—lymphatic system cancer	0.00572	0.00618	CcSEcCtD
Sevoflurane—Hepatic failure—Vincristine—lymphatic system cancer	0.00566	0.00612	CcSEcCtD
Sevoflurane—CYP3A4—Vincristine—lymphatic system cancer	0.00563	0.0748	CbGbCtD
Sevoflurane—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.00537	0.00581	CcSEcCtD
Sevoflurane—Hypoxia—Methotrexate—lymphatic system cancer	0.00535	0.00579	CcSEcCtD
Sevoflurane—Agitation—Teniposide—lymphatic system cancer	0.00525	0.00567	CcSEcCtD
Sevoflurane—Bronchospasm—Bleomycin—lymphatic system cancer	0.00519	0.00561	CcSEcCtD
Sevoflurane—Chills—Fludarabine—lymphatic system cancer	0.00517	0.00559	CcSEcCtD
Sevoflurane—Arrhythmia—Fludarabine—lymphatic system cancer	0.00515	0.00557	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00512	0.00554	CcSEcCtD
Sevoflurane—Malnutrition—Fludarabine—lymphatic system cancer	0.00502	0.00542	CcSEcCtD
Sevoflurane—Hypertension—Teniposide—lymphatic system cancer	0.00493	0.00533	CcSEcCtD
Sevoflurane—Liver function test abnormal—Carmustine—lymphatic system cancer	0.00492	0.00532	CcSEcCtD
Sevoflurane—Chest pain—Teniposide—lymphatic system cancer	0.00486	0.00525	CcSEcCtD
Sevoflurane—Cardiac arrest—Vincristine—lymphatic system cancer	0.00484	0.00523	CcSEcCtD
Sevoflurane—Urinary retention—Vincristine—lymphatic system cancer	0.00484	0.00523	CcSEcCtD
Sevoflurane—Confusional state—Teniposide—lymphatic system cancer	0.0047	0.00508	CcSEcCtD
Sevoflurane—Oedema—Teniposide—lymphatic system cancer	0.00466	0.00504	CcSEcCtD
Sevoflurane—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00466	0.00503	CcSEcCtD
Sevoflurane—Agitation—Fludarabine—lymphatic system cancer	0.00461	0.00499	CcSEcCtD
Sevoflurane—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00456	0.00493	CcSEcCtD
Sevoflurane—Tachycardia—Teniposide—lymphatic system cancer	0.00455	0.00492	CcSEcCtD
Sevoflurane—Pruritus—Mechlorethamine—lymphatic system cancer	0.00447	0.00483	CcSEcCtD
Sevoflurane—Cough—Fludarabine—lymphatic system cancer	0.00438	0.00473	CcSEcCtD
Sevoflurane—Hypotension—Teniposide—lymphatic system cancer	0.00435	0.00471	CcSEcCtD
Sevoflurane—Convulsion—Fludarabine—lymphatic system cancer	0.00435	0.0047	CcSEcCtD
Sevoflurane—Haemoglobin—Bleomycin—lymphatic system cancer	0.00425	0.00459	CcSEcCtD
Sevoflurane—Haemorrhage—Bleomycin—lymphatic system cancer	0.00422	0.00457	CcSEcCtD
Sevoflurane—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00416	0.00449	CcSEcCtD
Sevoflurane—Dyspnoea—Teniposide—lymphatic system cancer	0.00415	0.00449	CcSEcCtD
Sevoflurane—Confusional state—Fludarabine—lymphatic system cancer	0.00413	0.00446	CcSEcCtD
Sevoflurane—Dysuria—Vincristine—lymphatic system cancer	0.00411	0.00445	CcSEcCtD
Sevoflurane—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00409	0.00443	CcSEcCtD
Sevoflurane—Oedema—Fludarabine—lymphatic system cancer	0.00409	0.00443	CcSEcCtD
Sevoflurane—Renal failure—Carmustine—lymphatic system cancer	0.00404	0.00437	CcSEcCtD
Sevoflurane—Vomiting—Mechlorethamine—lymphatic system cancer	0.00402	0.00434	CcSEcCtD
Sevoflurane—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00401	0.00434	CcSEcCtD
Sevoflurane—Apnoea—Methotrexate—lymphatic system cancer	0.00401	0.00434	CcSEcCtD
Sevoflurane—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00401	0.00433	CcSEcCtD
Sevoflurane—Rash—Mechlorethamine—lymphatic system cancer	0.00398	0.00431	CcSEcCtD
Sevoflurane—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00398	0.0043	CcSEcCtD
Sevoflurane—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00386	0.00418	CcSEcCtD
Sevoflurane—Feeling abnormal—Teniposide—lymphatic system cancer	0.00384	0.00415	CcSEcCtD
Sevoflurane—Chills—Bleomycin—lymphatic system cancer	0.00379	0.0041	CcSEcCtD
Sevoflurane—Bone disorder—Methotrexate—lymphatic system cancer	0.00377	0.00407	CcSEcCtD
Sevoflurane—Renal failure—Mitoxantrone—lymphatic system cancer	0.00375	0.00406	CcSEcCtD
Sevoflurane—Nausea—Mechlorethamine—lymphatic system cancer	0.00375	0.00406	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Methotrexate—lymphatic system cancer	0.00374	0.00405	CcSEcCtD
Sevoflurane—Jaundice—Mitoxantrone—lymphatic system cancer	0.00372	0.00403	CcSEcCtD
Sevoflurane—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00371	0.00401	CcSEcCtD
Sevoflurane—Haemoglobin—Carmustine—lymphatic system cancer	0.00371	0.00401	CcSEcCtD
Sevoflurane—Urticaria—Teniposide—lymphatic system cancer	0.0037	0.004	CcSEcCtD
Sevoflurane—Oliguria—Methotrexate—lymphatic system cancer	0.00369	0.00399	CcSEcCtD
Sevoflurane—Haemorrhage—Carmustine—lymphatic system cancer	0.00369	0.00399	CcSEcCtD
Sevoflurane—Body temperature increased—Teniposide—lymphatic system cancer	0.00368	0.00398	CcSEcCtD
Sevoflurane—Dyspnoea—Fludarabine—lymphatic system cancer	0.00365	0.00395	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00353	0.00382	CcSEcCtD
Sevoflurane—Pain—Fludarabine—lymphatic system cancer	0.0035	0.00379	CcSEcCtD
Sevoflurane—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00349	0.00377	CcSEcCtD
Sevoflurane—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00348	0.00376	CcSEcCtD
Sevoflurane—Respiratory failure—Methotrexate—lymphatic system cancer	0.00346	0.00375	CcSEcCtD
Sevoflurane—Urethral disorder—Vincristine—lymphatic system cancer	0.00345	0.00373	CcSEcCtD
Sevoflurane—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00345	0.00373	CcSEcCtD
Sevoflurane—Hypersensitivity—Teniposide—lymphatic system cancer	0.00343	0.00371	CcSEcCtD
Sevoflurane—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00343	0.00371	CcSEcCtD
Sevoflurane—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00343	0.00371	CcSEcCtD
Sevoflurane—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.0034	0.00368	CcSEcCtD
Sevoflurane—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00337	0.00365	CcSEcCtD
Sevoflurane—Asthenia—Teniposide—lymphatic system cancer	0.00334	0.00361	CcSEcCtD
Sevoflurane—Pruritus—Teniposide—lymphatic system cancer	0.0033	0.00356	CcSEcCtD
Sevoflurane—Arrhythmia—Carmustine—lymphatic system cancer	0.00329	0.00356	CcSEcCtD
Sevoflurane—Cardiac disorder—Vincristine—lymphatic system cancer	0.00327	0.00353	CcSEcCtD
Sevoflurane—Body temperature increased—Fludarabine—lymphatic system cancer	0.00324	0.0035	CcSEcCtD
Sevoflurane—Mental disorder—Carmustine—lymphatic system cancer	0.00323	0.00349	CcSEcCtD
Sevoflurane—Malnutrition—Carmustine—lymphatic system cancer	0.00321	0.00347	CcSEcCtD
Sevoflurane—Cough—Bleomycin—lymphatic system cancer	0.00321	0.00347	CcSEcCtD
Sevoflurane—Angiopathy—Vincristine—lymphatic system cancer	0.00319	0.00345	CcSEcCtD
Sevoflurane—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00317	0.00343	CcSEcCtD
Sevoflurane—Chest pain—Bleomycin—lymphatic system cancer	0.00313	0.00339	CcSEcCtD
Sevoflurane—Mental disorder—Vincristine—lymphatic system cancer	0.00308	0.00334	CcSEcCtD
Sevoflurane—Chills—Mitoxantrone—lymphatic system cancer	0.00308	0.00333	CcSEcCtD
Sevoflurane—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00306	0.00331	CcSEcCtD
Sevoflurane—Confusional state—Bleomycin—lymphatic system cancer	0.00303	0.00327	CcSEcCtD
Sevoflurane—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00302	0.00326	CcSEcCtD
Sevoflurane—Oedema—Bleomycin—lymphatic system cancer	0.003	0.00325	CcSEcCtD
Sevoflurane—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.003	0.00325	CcSEcCtD
Sevoflurane—Vomiting—Teniposide—lymphatic system cancer	0.00296	0.0032	CcSEcCtD
Sevoflurane—Agitation—Carmustine—lymphatic system cancer	0.00295	0.00319	CcSEcCtD
Sevoflurane—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00294	0.00318	CcSEcCtD
Sevoflurane—Asthenia—Fludarabine—lymphatic system cancer	0.00294	0.00318	CcSEcCtD
Sevoflurane—Rash—Teniposide—lymphatic system cancer	0.00294	0.00318	CcSEcCtD
Sevoflurane—Dermatitis—Teniposide—lymphatic system cancer	0.00293	0.00317	CcSEcCtD
Sevoflurane—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00292	0.00316	CcSEcCtD
Sevoflurane—Headache—Teniposide—lymphatic system cancer	0.00292	0.00316	CcSEcCtD
Sevoflurane—Pruritus—Fludarabine—lymphatic system cancer	0.0029	0.00313	CcSEcCtD
Sevoflurane—Agitation—Vincristine—lymphatic system cancer	0.00282	0.00305	CcSEcCtD
Sevoflurane—Hypotension—Bleomycin—lymphatic system cancer	0.0028	0.00303	CcSEcCtD
Sevoflurane—Convulsion—Carmustine—lymphatic system cancer	0.00278	0.00301	CcSEcCtD
Sevoflurane—Hypertension—Carmustine—lymphatic system cancer	0.00277	0.003	CcSEcCtD
Sevoflurane—Nausea—Teniposide—lymphatic system cancer	0.00277	0.00299	CcSEcCtD
Sevoflurane—Hepatic failure—Methotrexate—lymphatic system cancer	0.00275	0.00297	CcSEcCtD
Sevoflurane—Chest pain—Carmustine—lymphatic system cancer	0.00273	0.00296	CcSEcCtD
Sevoflurane—Dyspnoea—Bleomycin—lymphatic system cancer	0.00268	0.00289	CcSEcCtD
Sevoflurane—Renal failure acute—Methotrexate—lymphatic system cancer	0.00267	0.00289	CcSEcCtD
Sevoflurane—Convulsion—Vincristine—lymphatic system cancer	0.00266	0.00287	CcSEcCtD
Sevoflurane—Hypertension—Vincristine—lymphatic system cancer	0.00265	0.00286	CcSEcCtD
Sevoflurane—Confusional state—Carmustine—lymphatic system cancer	0.00264	0.00286	CcSEcCtD
Sevoflurane—Oedema—Carmustine—lymphatic system cancer	0.00262	0.00283	CcSEcCtD
Sevoflurane—Cough—Mitoxantrone—lymphatic system cancer	0.0026	0.00282	CcSEcCtD
Sevoflurane—Vomiting—Fludarabine—lymphatic system cancer	0.0026	0.00281	CcSEcCtD
Sevoflurane—Convulsion—Mitoxantrone—lymphatic system cancer	0.00259	0.0028	CcSEcCtD
Sevoflurane—Rash—Fludarabine—lymphatic system cancer	0.00258	0.00279	CcSEcCtD
Sevoflurane—Dermatitis—Fludarabine—lymphatic system cancer	0.00258	0.00279	CcSEcCtD
Sevoflurane—Hypertension—Mitoxantrone—lymphatic system cancer	0.00258	0.00279	CcSEcCtD
Sevoflurane—Pain—Bleomycin—lymphatic system cancer	0.00257	0.00278	CcSEcCtD
Sevoflurane—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00257	0.00277	CcSEcCtD
Sevoflurane—Headache—Fludarabine—lymphatic system cancer	0.00256	0.00277	CcSEcCtD
Sevoflurane—Tachycardia—Carmustine—lymphatic system cancer	0.00256	0.00277	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00255	0.00276	CcSEcCtD
Sevoflurane—Chest pain—Mitoxantrone—lymphatic system cancer	0.00254	0.00275	CcSEcCtD
Sevoflurane—Anaphylactic shock—Vincristine—lymphatic system cancer	0.0025	0.0027	CcSEcCtD
Sevoflurane—Oedema—Vincristine—lymphatic system cancer	0.0025	0.0027	CcSEcCtD
Sevoflurane—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00247	0.00267	CcSEcCtD
Sevoflurane—Confusional state—Mitoxantrone—lymphatic system cancer	0.00246	0.00266	CcSEcCtD
Sevoflurane—Nervous system disorder—Vincristine—lymphatic system cancer	0.00245	0.00265	CcSEcCtD
Sevoflurane—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00245	0.00265	CcSEcCtD
Sevoflurane—Hypotension—Carmustine—lymphatic system cancer	0.00245	0.00265	CcSEcCtD
Sevoflurane—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00244	0.00263	CcSEcCtD
Sevoflurane—Oedema—Mitoxantrone—lymphatic system cancer	0.00244	0.00263	CcSEcCtD
Sevoflurane—Nausea—Fludarabine—lymphatic system cancer	0.00243	0.00263	CcSEcCtD
Sevoflurane—Shock—Mitoxantrone—lymphatic system cancer	0.0024	0.00259	CcSEcCtD
Sevoflurane—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00238	0.00258	CcSEcCtD
Sevoflurane—Urticaria—Bleomycin—lymphatic system cancer	0.00238	0.00258	CcSEcCtD
Sevoflurane—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00238	0.00257	CcSEcCtD
Sevoflurane—Body temperature increased—Bleomycin—lymphatic system cancer	0.00237	0.00257	CcSEcCtD
Sevoflurane—Insomnia—Carmustine—lymphatic system cancer	0.00237	0.00256	CcSEcCtD
Sevoflurane—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00237	0.00256	CcSEcCtD
Sevoflurane—Hypotension—Vincristine—lymphatic system cancer	0.00234	0.00253	CcSEcCtD
Sevoflurane—Dyspnoea—Carmustine—lymphatic system cancer	0.00234	0.00253	CcSEcCtD
Sevoflurane—Somnolence—Carmustine—lymphatic system cancer	0.00233	0.00252	CcSEcCtD
Sevoflurane—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00228	0.00247	CcSEcCtD
Sevoflurane—Hypotension—Mitoxantrone—lymphatic system cancer	0.00228	0.00246	CcSEcCtD
Sevoflurane—Insomnia—Vincristine—lymphatic system cancer	0.00226	0.00245	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00226	0.00245	CcSEcCtD
Sevoflurane—Pain—Carmustine—lymphatic system cancer	0.00224	0.00242	CcSEcCtD
Sevoflurane—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00221	0.00239	CcSEcCtD
Sevoflurane—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00217	0.00235	CcSEcCtD
Sevoflurane—Somnolence—Mitoxantrone—lymphatic system cancer	0.00217	0.00234	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00216	0.00234	CcSEcCtD
Sevoflurane—Feeling abnormal—Carmustine—lymphatic system cancer	0.00216	0.00233	CcSEcCtD
Sevoflurane—Asthenia—Bleomycin—lymphatic system cancer	0.00215	0.00233	CcSEcCtD
Sevoflurane—Pain—Vincristine—lymphatic system cancer	0.00214	0.00231	CcSEcCtD
Sevoflurane—Pruritus—Bleomycin—lymphatic system cancer	0.00212	0.0023	CcSEcCtD
Sevoflurane—Pancreatitis—Methotrexate—lymphatic system cancer	0.00209	0.00226	CcSEcCtD
Sevoflurane—Pain—Mitoxantrone—lymphatic system cancer	0.00208	0.00225	CcSEcCtD
Sevoflurane—Body temperature increased—Carmustine—lymphatic system cancer	0.00207	0.00224	CcSEcCtD
Sevoflurane—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00201	0.00217	CcSEcCtD
Sevoflurane—Dysuria—Methotrexate—lymphatic system cancer	0.002	0.00216	CcSEcCtD
Sevoflurane—Body temperature increased—Vincristine—lymphatic system cancer	0.00198	0.00214	CcSEcCtD
Sevoflurane—Urticaria—Mitoxantrone—lymphatic system cancer	0.00194	0.00209	CcSEcCtD
Sevoflurane—Hypersensitivity—Carmustine—lymphatic system cancer	0.00193	0.00209	CcSEcCtD
Sevoflurane—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00193	0.00208	CcSEcCtD
Sevoflurane—Vomiting—Bleomycin—lymphatic system cancer	0.00191	0.00206	CcSEcCtD
Sevoflurane—Rash—Bleomycin—lymphatic system cancer	0.00189	0.00205	CcSEcCtD
Sevoflurane—Dermatitis—Bleomycin—lymphatic system cancer	0.00189	0.00204	CcSEcCtD
Sevoflurane—Asthenia—Carmustine—lymphatic system cancer	0.00188	0.00203	CcSEcCtD
Sevoflurane—Renal failure—Methotrexate—lymphatic system cancer	0.00187	0.00202	CcSEcCtD
Sevoflurane—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00185	0.002	CcSEcCtD
Sevoflurane—Hypersensitivity—Vincristine—lymphatic system cancer	0.00184	0.00199	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.0018	0.00195	CcSEcCtD
Sevoflurane—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00179	0.00194	CcSEcCtD
Sevoflurane—Asthenia—Vincristine—lymphatic system cancer	0.00179	0.00194	CcSEcCtD
Sevoflurane—Nausea—Bleomycin—lymphatic system cancer	0.00178	0.00193	CcSEcCtD
Sevoflurane—Asthenia—Mitoxantrone—lymphatic system cancer	0.00175	0.00189	CcSEcCtD
Sevoflurane—Dizziness—Carmustine—lymphatic system cancer	0.00173	0.00187	CcSEcCtD
Sevoflurane—Haemoglobin—Methotrexate—lymphatic system cancer	0.00172	0.00186	CcSEcCtD
Sevoflurane—Haemorrhage—Methotrexate—lymphatic system cancer	0.00171	0.00185	CcSEcCtD
Sevoflurane—Hepatitis—Methotrexate—lymphatic system cancer	0.00171	0.00185	CcSEcCtD
Sevoflurane—Pharyngitis—Methotrexate—lymphatic system cancer	0.0017	0.00183	CcSEcCtD
Sevoflurane—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00169	0.00182	CcSEcCtD
Sevoflurane—Urethral disorder—Methotrexate—lymphatic system cancer	0.00167	0.00181	CcSEcCtD
Sevoflurane—Vomiting—Carmustine—lymphatic system cancer	0.00167	0.0018	CcSEcCtD
Sevoflurane—Dizziness—Vincristine—lymphatic system cancer	0.00165	0.00179	CcSEcCtD
Sevoflurane—Rash—Carmustine—lymphatic system cancer	0.00165	0.00179	CcSEcCtD
Sevoflurane—Dermatitis—Carmustine—lymphatic system cancer	0.00165	0.00178	CcSEcCtD
Sevoflurane—Headache—Carmustine—lymphatic system cancer	0.00164	0.00178	CcSEcCtD
Sevoflurane—Vomiting—Vincristine—lymphatic system cancer	0.00159	0.00172	CcSEcCtD
Sevoflurane—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00159	0.00171	CcSEcCtD
Sevoflurane—Rash—Vincristine—lymphatic system cancer	0.00158	0.00171	CcSEcCtD
Sevoflurane—Dermatitis—Vincristine—lymphatic system cancer	0.00158	0.0017	CcSEcCtD
Sevoflurane—Headache—Vincristine—lymphatic system cancer	0.00157	0.00169	CcSEcCtD
Sevoflurane—Nausea—Carmustine—lymphatic system cancer	0.00156	0.00168	CcSEcCtD
Sevoflurane—Angiopathy—Methotrexate—lymphatic system cancer	0.00155	0.00168	CcSEcCtD
Sevoflurane—Vomiting—Mitoxantrone—lymphatic system cancer	0.00155	0.00167	CcSEcCtD
Sevoflurane—Immune system disorder—Methotrexate—lymphatic system cancer	0.00154	0.00167	CcSEcCtD
Sevoflurane—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00154	0.00166	CcSEcCtD
Sevoflurane—Rash—Mitoxantrone—lymphatic system cancer	0.00154	0.00166	CcSEcCtD
Sevoflurane—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00153	0.00166	CcSEcCtD
Sevoflurane—Chills—Methotrexate—lymphatic system cancer	0.00153	0.00166	CcSEcCtD
Sevoflurane—Headache—Mitoxantrone—lymphatic system cancer	0.00153	0.00165	CcSEcCtD
Sevoflurane—Mental disorder—Methotrexate—lymphatic system cancer	0.0015	0.00162	CcSEcCtD
Sevoflurane—Malnutrition—Methotrexate—lymphatic system cancer	0.00149	0.00161	CcSEcCtD
Sevoflurane—Nausea—Vincristine—lymphatic system cancer	0.00149	0.00161	CcSEcCtD
Sevoflurane—Dysgeusia—Methotrexate—lymphatic system cancer	0.00146	0.00157	CcSEcCtD
Sevoflurane—Nausea—Mitoxantrone—lymphatic system cancer	0.00145	0.00156	CcSEcCtD
Sevoflurane—Cough—Methotrexate—lymphatic system cancer	0.0013	0.0014	CcSEcCtD
Sevoflurane—Convulsion—Methotrexate—lymphatic system cancer	0.00129	0.00139	CcSEcCtD
Sevoflurane—Chest pain—Methotrexate—lymphatic system cancer	0.00127	0.00137	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00126	0.00136	CcSEcCtD
Sevoflurane—Confusional state—Methotrexate—lymphatic system cancer	0.00122	0.00132	CcSEcCtD
Sevoflurane—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00121	0.00131	CcSEcCtD
Sevoflurane—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00119	0.00129	CcSEcCtD
Sevoflurane—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.00119	0.00128	CcSEcCtD
Sevoflurane—Skin disorder—Methotrexate—lymphatic system cancer	0.00118	0.00127	CcSEcCtD
Sevoflurane—Hypotension—Methotrexate—lymphatic system cancer	0.00113	0.00123	CcSEcCtD
Sevoflurane—Insomnia—Methotrexate—lymphatic system cancer	0.0011	0.00119	CcSEcCtD
Sevoflurane—Dyspnoea—Methotrexate—lymphatic system cancer	0.00108	0.00117	CcSEcCtD
Sevoflurane—Somnolence—Methotrexate—lymphatic system cancer	0.00108	0.00117	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00105	0.00113	CcSEcCtD
Sevoflurane—Pain—Methotrexate—lymphatic system cancer	0.00104	0.00112	CcSEcCtD
Sevoflurane—Feeling abnormal—Methotrexate—lymphatic system cancer	0.001	0.00108	CcSEcCtD
Sevoflurane—Urticaria—Methotrexate—lymphatic system cancer	0.000964	0.00104	CcSEcCtD
Sevoflurane—Body temperature increased—Methotrexate—lymphatic system cancer	0.000959	0.00104	CcSEcCtD
Sevoflurane—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000894	0.000967	CcSEcCtD
Sevoflurane—Asthenia—Methotrexate—lymphatic system cancer	0.000871	0.000942	CcSEcCtD
Sevoflurane—Pruritus—Methotrexate—lymphatic system cancer	0.000859	0.000929	CcSEcCtD
Sevoflurane—Dizziness—Methotrexate—lymphatic system cancer	0.000803	0.000868	CcSEcCtD
Sevoflurane—Vomiting—Methotrexate—lymphatic system cancer	0.000772	0.000834	CcSEcCtD
Sevoflurane—Rash—Methotrexate—lymphatic system cancer	0.000765	0.000828	CcSEcCtD
Sevoflurane—Dermatitis—Methotrexate—lymphatic system cancer	0.000764	0.000827	CcSEcCtD
Sevoflurane—Headache—Methotrexate—lymphatic system cancer	0.00076	0.000822	CcSEcCtD
Sevoflurane—Nausea—Methotrexate—lymphatic system cancer	0.000721	0.00078	CcSEcCtD
